Skip to main content

Rising out-of-pocket costs for dementia and neuropathy drugs lower patient adherence

By Stat News  
   February 21, 2020

As out-of-pocket costs rise for medicines used to treat certain neurologic disorders — such as dementia and neuropathy — patients are less likely to take their drugs as often as prescribed, according to a new study. And the findings are the latest indication that increasing drug costs may lead to worsening health and, consequently, higher health care expenses in the future.

Full story

Get the latest on healthcare leadership in your inbox.